Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$17.1 - $22.26 $4,223 - $5,498
-247 Reduced 19.16%
1,042 $23,000
Q3 2023

Nov 08, 2023

SELL
$16.75 - $48.98 $552 - $1,616
-33 Reduced 2.5%
1,289 $27,000
Q3 2022

Oct 17, 2022

SELL
$32.28 - $43.27 $871 - $1,168
-27 Reduced 2.0%
1,322 $52,000
Q2 2022

Aug 02, 2022

SELL
$27.52 - $37.99 $19,814 - $27,352
-720 Reduced 34.8%
1,349 $44,000
Q1 2022

May 09, 2022

SELL
$30.71 - $45.71 $74,901 - $111,486
-2,439 Reduced 54.1%
2,069 $68,000
Q4 2021

Feb 14, 2022

SELL
$37.06 - $47.11 $10,191 - $12,955
-275 Reduced 5.75%
4,508 $192,000
Q3 2021

Oct 29, 2021

BUY
$40.26 - $57.37 $10,950 - $15,604
272 Added 6.03%
4,783 $212,000
Q2 2021

Aug 11, 2021

BUY
$54.88 - $79.29 $23,543 - $34,015
429 Added 10.51%
4,511 $256,000
Q1 2021

May 11, 2021

SELL
$70.65 - $96.76 $5,722 - $7,837
-81 Reduced 1.95%
4,082 $306,000
Q4 2020

Feb 05, 2021

SELL
$58.41 - $89.06 $209,750 - $319,814
-3,591 Reduced 46.31%
4,163 $360,000
Q3 2020

Oct 30, 2020

BUY
$41.13 - $62.45 $18,508 - $28,102
450 Added 6.16%
7,754 $473,000
Q2 2020

Jul 22, 2020

SELL
$25.95 - $43.15 $3,555 - $5,911
-137 Reduced 1.84%
7,304 $304,000
Q1 2020

May 14, 2020

BUY
$26.15 - $77.24 $120,760 - $356,694
4,618 Added 163.58%
7,441 $214,000
Q4 2019

Feb 10, 2020

BUY
$60.18 - $154.77 $169,888 - $436,915
2,823 New
2,823 $204,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $641M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.